Drugs / Givopegsomatropin
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07614152 Comparator | Jun 2026 → Mar 2028 expected | Turner syndrome | Xiamen Amoytop Biotech Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Givopegsomatropin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07614152 ↗ |
| Route | Subcutaneous | “s.c.” NCT07614152 ↗ |